Latest Articles
Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients - News-Medical
Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients News-Medical
Published: May 30, 2026, 2:16 a.m.
Inside Pete Davidson and Elsie Hewitt's Romance Before Their Split - RadarOnline
Inside Pete Davidson and Elsie Hewitt's Romance Before Their Split RadarOnline
Published: May 30, 2026, 12:45 a.m.
Pembrolizumab Plus Chemotherapy Shows Sustained Survival in Advanced EC - CancerNetwork
Pembrolizumab Plus Chemotherapy Shows Sustained Survival in Advanced EC CancerNetwork
Published: May 30, 2026, 12:40 a.m.
First responders continue recovery two weeks after deadly Robbins Lumber explosion - newscentermaine.com
First responders continue recovery two weeks after deadly Robbins Lumber explosion newscentermaine.com
Published: May 30, 2026, 12:38 a.m.
Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer - OncLive
Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer OncLive
Published: May 30, 2026, 12:24 a.m.
Pembrolizumab Plus Chemotherapy Shows Long-Term OS Benefit in Advanced/Recurrent Endometrial Cancer - OncLive
Pembrolizumab Plus Chemotherapy Shows Long-Term OS Benefit in Advanced/Recurrent Endometrial Cancer OncLive
Published: May 29, 2026, 11:57 p.m.
Immunotherapy Addition Demonstrates Sustained Survival Benefits in - Bioengineer.org
Immunotherapy Addition Demonstrates Sustained Survival Benefits in Bioengineer.org
Published: May 29, 2026, 11:56 p.m.
🔴 Crohns disease and ulcerative colitis are among the list of confirmed conditions - facebook.com
🔴 Crohns disease and ulcerative colitis are among the list of confirmed conditions facebook.com
Published: May 29, 2026, 11:35 p.m.
Dostarlimab Plus Chemotherapy Yields Curative Potential in dMMR/MSI-H Endometrial Cancer - CancerNetwork
Dostarlimab Plus Chemotherapy Yields Curative Potential in dMMR/MSI-H Endometrial Cancer CancerNetwork
Published: May 29, 2026, 10:40 p.m.
MSU researchers given millions of dollars to search for endometriosis cure - WLNS 6 News
MSU researchers given millions of dollars to search for endometriosis cure WLNS 6 News
Published: May 29, 2026, 10:25 p.m.
Link copied to clipboard!